Category: Cancer

Ponatinib (trade name Iclusig /aklus/ eye-KLOO-sig, previously AP24534) is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor.[2] Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these... [wikipedia]

1 Discussion

Related Brands

Drugs with the same active ingredients

Popular Topics


Treatments ## Hello, Akfuma! How are you? Ponatinib is used to treat several types of Leukemia. Learn more Ponatinib det...